A multicenter virome analysis of blood, feces, and saliva in myalgic encephalomyelitis/chronic fatigue syndrome.
Thomas BrieseRafal TokarzLucinda BatemanXiaoyu CheCheng GuoKomal JainVishal KapoorSusan LevineMady HornigAlexandra OleynikPhenix-Lan QuanWai H WongBrent L WilliamsSuzanne D VernonNancy G KlimasDaniel L PetersonJose G MontoyaWalter Ian LipkinPublished in: Journal of medical virology (2023)
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is estimated to affect 0.4%-2.5% of the global population. Most cases are unexplained; however, some patients describe an antecedent viral infection or response to antiviral medications. We report here a multicenter study for the presence of viral nucleic acid in blood, feces, and saliva of patients with ME/CFS using polymerase chain reaction and high-throughput sequencing. We found no consistent group-specific differences other than a lower prevalence of anelloviruses in cases compared to healthy controls. Our findings suggest that future investigations into viral infections in ME/CFS should focus on adaptive immune responses rather than surveillance for viral gene products.
Keyphrases
- sars cov
- nucleic acid
- immune response
- end stage renal disease
- high throughput sequencing
- newly diagnosed
- ejection fraction
- chronic kidney disease
- sleep quality
- case report
- prognostic factors
- genome wide
- gene expression
- copy number
- cross sectional
- current status
- drug induced
- inflammatory response
- dna methylation
- dendritic cells